Free Trial

Grifols: Cross Asset Moves - Awaiting CNMV Response

HEALTHCARE

Grifols (GRF SM) cross-asset moves: equity one of weakest in SXXP, cash curve tightening.


  • Grifols results (on 29-Feb) results last week were solid at the revenue level but missed at net income which drove the equity lower. However, credit metrics (FCF and leverage) were both better than expected.
  • Most importantly for near-term credit is the deal to sell S-RAAS to Haier Group. Here, mgmt confirmed that due diligence had been completed and the deal was now subject to normal regulatory approval. Mgmt was clear that the ’25 maturities would be dealt with following this sale.
  • News today of some small shareholding moves has, apparently, spooked equity markets again but, positively, its credit stack is broadly tighter today. Our view is that the equity will remain immensely volatile, especially ahead of hearing back from the Spanish regulator over its recent questioning of the firm

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.